Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
First-line therapy for type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study
Every persons body responds differently, so taking a one-size-fits-all approach usually leads to frustration
The GLP-1 agonist is the first drug from the collaboration, spanning multiple compounds and therapeutic categories, and was selected for clinical development in 2019
And the company behind it, Novo Nordisk, has been so successful, it has singlehandedly changed the economy of its home country Denmark for the better
US$ 28.11
US$ 23.52
US$ 24.17
US$ 29.85
US$ 25.16
US$ 20.86
US$ 20.86
US$ 24.26
US$ 29.43
US$ 21.42
